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Abstract 
Existence of disharmony in sustaining attention and working memory in stimulants abusers and opioids abusers in Iran is 
observable. The performance of tree group of people included 30 normal person, 27 opioids addict, and 26 stimulant addicts in 
Paced visual Serial Addition Test (PVSAT) as a measure of sustaining attention and working memory was assessed in this 
research. Significant difference were observed in sustaining attention, and working memory between tree groups of control 
(whom never use drugs) and experiments (those are addicted to opioids or stimulants); but there were no significant between two
groups of addicted subjects which use opioids or stimulants. 
© 2010 Elsevier Ltd.
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1. Introduction 
There is a consensus that all drugs create a disharmony in the neuropsychological network, causing a decrease of 
activity in areas responsible for short-term memory, attention, and executive functioning with the possible exception 
of heroin. It is worth pointing out the effort made in many of these studies to relate quantity and chronicity measures 
of drug use with the magnitude of the neuropsychological impairments. Due to the absence of a more profound 
knowledge about the cause–effect relationships in the area of the neuropsychology of drug dependence, and the 
considerable methodological difficulties associated to longitudinal studies, these chronicity and severity-related 
measures can provide important support for the hypothesis that drugs generate neuropsychological alterations, and 
not the other way around. Brain Imaging Techniques on the other hand reveal that changes in brain function differ 
between drugs, but neuropsychological assessments show similar results or no changes in function. (Lundqvist, 
2005).
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H 1.1. Methamphetamine 
Neuroimaging studies have demonstrated that methamphetamine user exhibits various abnormalities in brain 
function relative to healthy controls. These include alterations in frontal, temporal, and sub cortical brain 
metabolism (HGouzoulis-Mayfrank et al., 1999H, HIyo et al., 1997H and HVolkow et al., 2001aH), changes in brain 
metabolites suggestive of neuronal injury in the basal ganglia and frontal cortex (HErnst et al., 2000H), and decreased 
density of dopaminergic neurons in the caudate and putamen (HMcCann et al., 1998H, HSekine et al., 2001H and HVolkow 
et al., 2001bH). Few studies have explicitly attempted to examine the cognitive functioning of methamphetamine 
users, recent investigations have documented deficits in learning, delayed recall, processing speed, and working 
memory (HRippeth et al., 2004H and HSimon et al., 2000H).
1.2. Cannabis 
Qualitative analyses of the cognitive consequences of cannabis use made by H all et al. (1999)H conclude, focusing 
on: acute effects that, cannabis induces loss of internal control and cognitive impairment, especially of attention and 
memory, for the duration of intoxication. Further, according to H all et al. (1999)H, the major health and 
psychological effects of chronic heavy cannabis use, especially daily use over many years, remain uncertain. On the 
available evidence, the major probable adverse chronic effects on cognition appear to be development of a cannabis 
dependence syndrome, characterized by an inability to abstain from or to control cannabis use; subtle forms of 
cognitive impairment, most particularly of attention and memory, which persist while the user remains chronically 
intoxicated, and may or may not be reversible after prolonged abstinence from cannabis. 
Both neuropsychological assessment studies and studies based on brain imaging techniques indicate that deficits in 
attention, memory and executive functioning. Acute neuropsychological effects (within 12–24 h) of cannabis use 
include deficits in attention, executive functioning, and short-term memory (HO'Leary et al., 2002H and HPope et al., 
1995H).Some studies indicate long-term effects (after 24 h–28 days) on short-memory and attention (HBolla et al., 
2002H, HEldreth et al., 2004H, HPope et al., 2001H and HSchwartz et al., 1989H).
1.3. Opioid  
HPau et al. (2002)H examined the impact of heroin on frontal executive functioning in three cognitive domains, namely 
attention, impulse control, and mental flexibility and abstract reasoning. The findings indicate that heroin addiction 
has a negative effect on impulse control, while attention and mental flexibility/abstract reasoning ability were not 
affected
HDavis et al. (2002)H examined cognitive functioning in people with a current or past history of opiate abuse using 
a range of neuropsychological tests. The findings in the study suggest subtle impulse control difficulty as a result of 
5 years of heroin use. Other appeared to be unaffected. Most neuropsychological and electroencephalographic 
studies of drug abusers showed less profound brain dysfunction in chronic opiate addicts compared to chronic 
psychostimulant users (H ill and Mikhael, 1979H, HCosta and Bauer, 1997H, HRogers et al., 1999H, HArzumanov, 2001H and 
HBauer, 2002H). But some neuropsychological deficits in opiate abusers were also reported. Medicated heroin addicts 
usually demonstrate impairment on psychomotor speed and attention tests, which may be in part attributed to 
sedative medication effects (HDarke et al., 2000H, HSpecka et al., 2000H, HBriun et al., 2001H, HDavis et al., 2002H and 
HMintzer and Stitzer, 2002H). A proportion of opiate addicts exhibits broader cognitive impairment in comparison to 
other patients, and this fact is usually interpreted as a premorbid or concomitant brain damage in some heroin 
addicts (H ill and Mikhael, 1979H, HBriun et al., 2002H and HDavis et al., 2002H).
2. Materials and methods 
2.1. Subjects 
Among the 83 participating in this study, 30 normal men, 27 men opioids addicted and 26 men who were addicted to 
stimulant were present. All the patients abused drug at least 6 months. Thirty healthy male volunteers with no 
history of drug abuse were chosen to match the drug abuse groups as closely as possible for years of education but 
our opioids addicts were younger than the other one. 
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2.2. Procedure 
Assessing of the performance of tree group of people in Paced visual Serial Addition Test (PVSAT) as a measure 
of sustaining attention and working memory was the purpose of this study. In this task a random series of digit 
presented on monitor of computer and the participant is to add the last digit presented to the preceding digit and 
verbalize the answer. The space at which the digits are presented differs for two trials. In trial 1 the digits are 
presented at the rate of 2 seconds and in trial 2 at 3 seconds. 
3. Results 
One-way ANOVA was used to investigate differences in three groups. And t-test was used to investigate 
difference for two groups. Significant difference were observed in sustaining attention, and working memory 
between tree groups of control (whom never use opioids) and experiments (those are addicted to opioids or 
stimulants)in trial2 but not in trial 1 ; and there were significant difference between two groups of addicted 
subjects which use opioids or stimulants in trial 1 but not in trial 2. The average of age, education, and the scores 
of two trials of the task are presented in table1. 
 Table1. Demographic characteristics and trials scores
Groups Age(mean) education(mean) Score of trial1(mean) 
Score of 
 trial2(mean) 
Control Group 27 11 45 52
stimulant addicts 30.6 11.3 41.7 45
opium addicts 24.7 10.9 40 45
4. Discussion 
This Study results about comparison of stimulant addict and normal group are similar to earlier studies but about 
opioid addicts are completely different. Because earlier studies showed that stimulants decreases sustaining attention 
and working memory, etc but opioids haven’t any effects on attention and working memory. Absolutely it is because 
of abusing a new drug in Iran named Crak which procures from heroin attend heroin and opium that needs more 
study. 
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